Digital Health

CVS Health is expanding its pharmacy offering to include pet medications (antibiotics, allergy, flea/tick control, insulin, pain relievers) across ~9,000 locations nationwide, with digital integration into the CVS app and electronic prescription capabilities coming soon.

Leadership read: Product momentum tends to widen digital health product and commercial leadership bench strength.

curated · 2026-07-21 · context →

GE HealthCare officially launched MIM Anyware, a secure web-based platform for remote imaging access and real-time clinical collaboration in cancer care

Leadership read: Product momentum tends to widen digital health product and commercial leadership bench strength.

curated · 2026-07-20 · context →

Neko Health (backed by Spotify founder) raises $700M for US expansion

Leadership read: Fresh capital usually broadens digital health leadership bench strength — scale, go-to-market and operational depth — rather than any single appointment.

curated · 2026-07-17 · context →

Innovaccer formally launched Gravity for Infusion, a specialized AI infrastructure platform targeting the $100 billion U.S. infusion therapy market. The platform automates referral intake, benefits verification, prior authorization, and appointment scheduling for ambulatory infusion centers.

Leadership read: Product momentum tends to widen digital health product and commercial leadership bench strength.

curated · 2026-07-17 · context →

GE HealthCare signed a 10-year strategic alliance with Catholic Health valued at approximately $500 million to expand access to precision diagnostics, advanced imaging, and AI-supported technology across Catholic Health's network in Long Island, US.

Leadership read: A 10-year, $500 million commitment is not a vendor contract — it is an operating architecture decision. Catholic Health has effectively outsourced the technology roadmap for precision diagnostics and AI-supported imaging across its Long Island network for a decade, which means clinical procurement, capital planning, and technology governance functions inside that system are now subordinated to a joint roadmap rather than internal deliberation. For GE HealthCare, this converts a customer relationship into an embedded infrastructure position: performance against AI adoption and diagnostic access metrics becomes a contractual obligation, not a sales aspiration. That is a fundamentally different accountability structure than project-based deployments. The related signals available here are thin on direct comparables — the 12 partnership signals tracked in the same window are weighted heavily toward fintech, crypto infrastructure, and media, with only one health-adjacent signal (Flexzo AI / Maiden Lane Medical on clinician recruitment). That limits the pattern count in this specific corridor to the GE HealthCare deal itself as the primary data point. What can be said is that long-duration enterprise alliances in regulated sectors are the structural form that appears when a technology provider needs predictable deployment volume to justify AI product investment at scale. Across companies operating at this stage of embedded, multi-year health-system alliances, the functional pressure concentrates in a consistent set of areas: outcomes and performance operations capable of managing against contractual clinical metrics, AI product leadership with regulatory and clinical-workflow fluency, and commercial partnership functions that can govern joint roadmaps rather than transact renewals.

curated · 2026-07-17 · context →

Digitas appointed Jack Delmonte as Executive Creative Director (ECD). Delmonte was previously Group Creative Director at VML.

Leadership read: Digitas elevated its creative function at the ECD level — a role that sits above individual campaign execution and carries accountability for creative platform, talent culture, and client creative relationships at a portfolio level. Delmonte's move from VML, one of the larger network shops, into Digitas places someone with network-scale creative operations experience inside a data-and-technology-positioned agency brand. That combination — production-grade creative leadership meeting a digitally integrated agency model — is the operational bet embedded in the appointment. This is one of 12 leadership changes we have tracked across media, marketing, and adjacent sectors in the last 90 days. The directly comparable moves inside the media and agency corridor include Andrew Cambridge taking the CEO seat at Initiative and Hannah Jones ascending to CEO of Sparro and Jack Nimble. The shape across these appointments is consistent: organizations are filling senior leadership gaps at either the top of the P&L or the top of creative and commercial functions, rarely mid-tier. The pattern points to agencies tightening their bench at the layer that owns client outcomes directly. Across agencies reaching this stage of creative-function repositioning, the market is moving toward operators who can bridge data-led strategy with craft-level creative output — a functional seam that creates rising demand for creative leadership with demonstrated platform-building experience, alongside commercial leads who can sell integrated capability rather than individual service lines.

curated · 2026-07-15 · context →

Neko Health expanding from UK/Sweden into US market with New York launch and additional cities planned for 2026

Leadership read: Market entry of this kind typically deepens demand for digital health leadership bench strength in the region over the following 12–18 months.

curated · 2026-07-15 · context →

Digital Turbine unveiled new fiscal 2027 revenue and EBITDA targets alongside expanded partnerships with Orange, Google Cloud, and Databricks for app distribution and mobile data intelligence platform

Leadership read: Alliances like this can broaden digital health commercial leadership bench strength.

curated · 2026-07-11 · context →

Wellhub launching first major US-market brand campaign with Terry Crews, produced by Surreal Hotel Arts. Campaign marks acceleration of US growth and expansion of platform beyond fitness to include mental health, mindfulness, nutrition, therapy, sleep services.

Leadership read: Product momentum tends to widen digital health product and commercial leadership bench strength.

curated · 2026-07-10 · context →

Stephen Hemsley returned as CEO of UnitedHealth Group after the company unexpectedly lost its previous chief executive. This leadership transition follows a period of operational challenges, including cost underestimation and regulatory scrutiny.

Leadership read: The operational reality behind Hemsley's return is not a routine succession — it is a stabilization mandate imposed by compounding failures across three distinct domains simultaneously: actuarial discipline, regulatory standing, and investor confidence. UnitedHealth entered this period having materially mispriced medical cost trends in Medicare Advantage, while simultaneously facing a DOJ probe into those same operations. A returning founder-era CEO carrying institutional authority is a specific instrument for that specific crisis: capable of compressing the internal deliberation that a newly external hire could not. The completed independent audit and revised operating controls represent durable structural commitments, not messaging — the company has now set a compliance baseline against which future performance will be measured. This is one of twelve leadership-change signals we have tracked in the last 90 days, though the UnitedHealth case stands apart from most in the set. Comparable transitions — CrossFit returning its former COO as CEO, EchoStar's chairman absorbing CEO duties after a resignation — share the same structural logic: institutional continuity deployed under duress rather than planned succession. The pattern is concentrated in organizations where external trust has eroded faster than internal capability. Across large regulated enterprises navigating simultaneous actuarial, regulatory, and reputational stress, the functional demand concentrating right now is in compliance architecture, government-affairs leadership with Medicare Advantage program depth, and financial risk leadership that sits at the intersection of underwriting and external audit readiness. The market is moving toward operators who can hold those three domains in tension without allowing any one to subordinate the others.

curated · 2026-07-07 · context →

Hims & Hers moved media account from Tinuiti to PMG following competitive review

Leadership read: Hims & Hers entered 2025 spending $237 million on measured media and exited it having cut that figure to $198 million — a 17% reduction that reframes this review. The shift from Tinuiti to PMG is not simply a competitive win for one independent; it marks a deliberate reset of how the company allocates media at reduced scale. Tinuiti built the Super Bowl relationship. PMG brings a stronger orientation toward full-funnel performance and premium digital environments. The operational commitment is to do more with less, which puts media efficiency and attribution rigor at the center of the new agency relationship from day one. This is one of twelve partnership signals we have tracked in the last 90 days across consumer health and direct-to-consumer media categories, though the related set here is thin on direct comparables. The cleaner parallel lives inside the broader agency review wave: IBM ending a 32-year Ogilvy relationship, Microsoft Copilot moving to Droga5, Levi's dissolving its AOR model entirely. The through-line is brands reorienting agency relationships around performance accountability and creative precision as total spend compresses. Companies at Hims & Hers' stage of DTC maturity — high media intensity, margin pressure, regulatory scrutiny on health claims — face concentrated demand for commercial leadership capable of operating at the intersection of performance marketing, brand stewardship, and compliant messaging. The market is moving toward operators who can govern agency ecosystems rather than simply manage single-agency mandates.

curated · 2026-07-06 · context →

Neko Health, the healthcare company owned by Daniel Ek, raised 265 million SEK (~$24-25 million USD equivalent) and recently opened a clinic in New York as part of geographic expansion.

Leadership read: Neko Health entered the US market operationally — not as a pilot or partnership — with a physical clinic in New York, committing to the clinical, regulatory, and commercial infrastructure that US healthcare delivery requires. The capital raise, coming despite a reportedly strong existing cash position, reads as runway extension timed to geographic expansion rather than a response to financial pressure. That sequencing matters: it signals the company is funding the US build-out proactively, which implies the clinic is a beachhead, not a one-off. The related signals from the last 90 days are broadly spread across energy, fintech, and deep tech; none maps cleanly to consumer health or preventive diagnostics. The Neko raise sits somewhat alone in this set, which limits pattern inference from these comparables specifically. The broader trend it belongs to — founder-led health companies using European positioning to enter the US premium wellness market — is active but tracked separately. Companies at this stage of cross-border clinical expansion consistently face demand for leadership at the intersection of regulatory operations (US healthcare licensing, state-level compliance), commercial development in a DTC-adjacent model, and clinical operations capable of scaling a standardized protocol across geographically dispersed sites. The market is moving toward operators who can hold clinical fidelity while running a consumer-grade growth motion — a narrow functional overlap that makes those profiles genuinely scarce.

curated · 2026-07-03 · context →